ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 14 - Ongoing Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ongoing Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ongoing Phase Today - Breaking & Trending Today
Advaxis to Present Updated Clinical and Immunogenicity Data
Overall response rate of 14% and disease control rate of 36% in Part B of ADXS-503 trial with durable clinical benefit as an add-on therapy to patients...
Source: globenewswire.com
Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association Congress. Partner Menarini Group to present clinical poster on SEL24 (MEN1703)
/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address...
Source: prnewswire.com
Rubius Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Presented Updated Clinical Data from Monotherapy Phase 1 Arm of RTX-240 Clinical Trial in Advanced Solid Tumors, Showing Clinical Responses with Favorable Tolerability in PD-1 Refractory Disease ... | May 10, 2022
Source: marketscreener.com
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com